A Randomized Controlled Study to Assess the Effects of Bisoprolol and Atenolol on Resting Heart Rate and Sympathetic Nervous System's Activity in Subjects With Essential Hypertension

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 177 participants.

Also called NCT01251146

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 177 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01251146
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01251146. Randomized; no masking; primary purpose treatment. Start 2010-11 (registry gives no type); primary completion 2012-02 (actual). Results posted on 2012-11-30.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Randomized Controlled Study to Assess the Effects of Bisoprolol and Atenolol on Resting Heart Rate and Sympathetic Nervous System's Activity in Subjects With Essential Hypertension
Condition
Hypertension
Intervention (Drug)
Bisoprolol
Intervention (Drug)
Atenolol
Lead sponsor
Merck KGaA, Darmstadt, Germany (class: industry)
Collaborator
Merck Serono Co., Ltd., China (class: industry)

Record details

Record id
cardio:ct-nct01251146
Content hash
5da8f606731d792ba3cb11b593bef82fd8b4209cd8d7710df784831cfc862f9e